Prokidney (PROK) Interest Expenses (2021 - 2026)
Prokidney's (PROK) quarterly Interest Expenses came in at $13.2 million in Q1 2026, down 0.69% year-on-year from $13.3 million in Q1 2025, and down 69.34% on a QoQ basis from $42.9 million in Q4 2025.
Prokidney (PROK) Interest Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Interest Expenses data on file, last reported at $13.2 million in Q1 2026.
- On a quarterly basis, Interest Expenses fell 0.69% year-over-year to $13.2 million in Q1 2026; TTM through Mar 2026 was $80.9 million, a 173.25% increase from a year earlier, with the FY2025 full-year figure at $42.9 million, up 118.01% from the prior year.
- Interest Expenses for Q1 2026 stood at $13.2 million, down from $42.9 million in the prior quarter.
- Over the last five years, Interest Expenses for PROK reached as high as $3.6 billion in Q1 2023 and fell as low as $2000.0 in Q4 2024.
- Historically, Interest Expenses has averaged $220.4 million across 5 years, with a median of $4.0 million in 2024.
- On a YoY basis, Interest Expenses climbed as much as 25735614.29% in 2023 and fell as far as 99.99% in 2023.
- Year by year, Interest Expenses stood at $24.8 million in 2022, then sank by 99.99% to $3000.0 in 2023, then plunged by 33.33% to $2000.0 in 2024, then jumped by 2146300.0% to $42.9 million in 2025, then slumped by 69.34% to $13.2 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $13.2 million in Q1 2026, $42.9 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Prokidney | 95.39 Mn | 95.39 Mn | - | 13.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.16 Mn |
| Mar 31, 2026 | 13.16 Mn |
| Dec 31, 2025 | 42.93 Mn |
| Dec 31, 2025 | 42.93 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 11.60 Mn |
| Jun 30, 2025 | 11.60 Mn |
| Mar 31, 2025 | 13.25 Mn |
| Mar 31, 2025 | 13.25 Mn |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2.20 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Jun 30, 2024 | 12.33 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |